EAU 2020: The New Testis Cancer Biomarker miRNA 371: Ready for Prime Time?
(UroToday.com) As part of a plenary presentation at the 2020 European Urologic Association Virtual Annual Meeting assessing “Testis cancer and surgical andrology,” Robert Hamilton, MD, MPH, FRCSC, examined whether miRNA-371 is ready for “prime time” as a testis cancer biomarker. He began by giving an overview of the landscape of testis cancer in which better […]
